These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 20940327)

  • 21. [A simple procedure for the immunoturbidimetric determination of apolipoprotein B].
    Winkler L; Schlag B; Zieger M; Rüger L; Dargel R
    Z Med Lab Diagn; 1984; 25(6):307-12. PubMed ID: 6495813
    [No Abstract]   [Full Text] [Related]  

  • 22. [The importance of A1 and B apoproteins as cardiovascular risk markers].
    Sánchez FM; Albo Castaño MI; Casallo Blanco S; Vizuete Calero A; Matías Salces Ld
    An Med Interna; 2008 Apr; 25(4):199-200. PubMed ID: 18604341
    [No Abstract]   [Full Text] [Related]  

  • 23. [A variant method for immunoturbidimetric determination of apolipoproteins A-I and B in the serum].
    Winkler L; Schlag B; Rüger HJ; Dargel R
    Z Med Lab Diagn; 1986; 27(7):372-6. PubMed ID: 3101301
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum concentrations of apolipoprotein A-I, apolipoprotein B, and lipoprotein(a) in a population sample.
    Leino A; Impivaara O; Kaitsaari M; Järvisalo J
    Clin Chem; 1995 Nov; 41(11):1633-6. PubMed ID: 7586554
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Plasma apolipoproteins AI and B: reference values in the Isère population and determination of individual values].
    Foulon T; Laporte F; Payen N; Groslambert P
    Ann Biol Clin (Paris); 1998; 56(4):451-6. PubMed ID: 9754281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Apo B/apo A-I ratio and cardiovascular risk prediction.
    Lima LM; Carvalho Md; Sousa MO
    Arq Bras Cardiol; 2007 Jun; 88(6):e187-90. PubMed ID: 17664987
    [No Abstract]   [Full Text] [Related]  

  • 27. Apolipoprotein-defined lipoprotein abnormalities in rheumatoid arthritis patients and their potential impact on cardiovascular disease.
    Knowlton N; Wages JA; Centola MB; Alaupovic P
    Scand J Rheumatol; 2012 May; 41(3):165-9. PubMed ID: 22401593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risks and benefits of replacing conventional plasma lipids with apolipoprotein measurement.
    Lippi G; Targher G; Guidi GC
    Acta Cardiol; 2009 Jun; 64(3):413-4; author reply 414. PubMed ID: 19593956
    [No Abstract]   [Full Text] [Related]  

  • 29. A new rapid micromethod for the assay of phenobarbital from dried blood spots by LC-tandem mass spectrometry.
    la Marca G; Malvagia S; Filippi L; Luceri F; Moneti G; Guerrini R
    Epilepsia; 2009 Dec; 50(12):2658-62. PubMed ID: 19682026
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunoturbidimetric assays of apolipoproteins A, AI, AII, and B in serum.
    Rifai N; King ME
    Clin Chem; 1986 Jun; 32(6):957-61. PubMed ID: 3085982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The apoB/apoA-I ratio and insulin resistance: sorting out the metabolic syndrome.
    Sniderman AD
    Eur Heart J; 2007 Nov; 28(21):2563-4. PubMed ID: 17905791
    [No Abstract]   [Full Text] [Related]  

  • 32. Reference values for apolipoproteins A-I and B in healthy subjects, by age.
    Zunić G; Jelić-Ivanović Z; Spasić S; Stojiljković A; Majkić-Singh N
    Clin Chem; 1992 Apr; 38(4):566-9. PubMed ID: 1568324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gold-labeled nanoparticle-based immunoresonance scattering spectral assay for trace apolipoprotein AI and apolipoprotein B.
    Jiang Z; Sun S; Liang A; Huang W; Qin A
    Clin Chem; 2006 Jul; 52(7):1389-94. PubMed ID: 16798966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The determination of urinary free and conjugated cortisol using UPLC-MS/MS.
    Ming DS; Heathcote J; Garg A; Darbyshire J; Eagleston E; Bajkov TL
    Bioanalysis; 2011 Feb; 3(3):301-12. PubMed ID: 21320051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A new panel of pancreatic cancer biomarkers discovered using a mass spectrometry-based pipeline.
    Liu X; Zheng W; Wang W; Shen H; Liu L; Lou W; Wang X; Yang P
    Br J Cancer; 2017 Dec; 117(12):1846-1854. PubMed ID: 29123261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicenter evaluation of automated immunoturbidimetric assays for measurement of apolipoproteins A-I and B in serum and plasma.
    Kahn SE; Labbé RF; Pfadenhauer EH; Kanonchoff AD; Joseph RT
    Clin Chem; 1994 Sep; 40(9):1722-9. PubMed ID: 8070082
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitation of serum apolipoprotein A-I, A-II, B, C-II, C-III and E in healthy Japanese by turbidimetric immunoassay: reference values, and age- and sex-related differences.
    Noma A; Hata Y; Goto Y
    Clin Chim Acta; 1991 Jun; 199(2):147-57. PubMed ID: 1908362
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimation of carbamazepine and carbamazepine-10,11-epoxide concentrations in plasma using mathematical equations generated with two carbamazepine immunoassays.
    McMillin GA; Juenke JM; Tso G; Dasgupta A
    Am J Clin Pathol; 2010 May; 133(5):728-36. PubMed ID: 20395519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantification of cystatin-C in human serum by stable isotope dilution liquid chromatography electrospray ionization tandem mass spectrometry.
    Ji H; Wang J; Ju S; Cong H; Wang X; Su J; Wang H
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Aug; 1059():49-55. PubMed ID: 28578261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neonatal screening for familial hypercholesterolaemia by immunoturbidimetric assay of apolipoprotein B in dried blood spots.
    Bangert SK; Eldridge PH; Peters TJ
    Clin Chim Acta; 1992 Dec; 213(1-3):95-101. PubMed ID: 1477991
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.